InvestorNewsBreaks – Safety Shot (NASDAQ: SHOT) Plans to Develop Detox Product, File IND with FDA

September 18, 2023 10:29:28

Safety Shot (NASDAQ: SHOT), formerly known as Jupiter Wellness, is looking to develop its Safety Shot functional beverage platform. The company announced plans to develop a concentrated form of its proprietary Safety Shot offering designed to treat alcohol poisoning in hospital and emergency settings. The Safety Shot beverage, which is slated for a Q4 2023 launch, is the first patented beverage that helps people feel better faster by reducing blood alcohol content and boosting clarity. The company believes a concentrated form of the beverage has potential as a rapid treatment for alcohol poising, which causes 2,200 deaths each year and leads to 52 million hospital emergency department visits a year from people suffering from acute alcohol consumption. “We believe a concentrated form of Safety Shot could offer an easy-to-administer, immediately supportive aid or treatment for acute alcohol consumption to help prevent alcohol poisoning and related deaths,” said Safety Shot chief scientific officer Dr. Glynn Wilson in the press release. “With 52 million people rushed to the ER each year due to acute alcohol consumption, we believe that prescription-grade Safety Shot could be used in a variety of settings including ambulances, hospitals, clinics, and entertainment venue-based medical emergency centers. We anticipate filing an investigational new drug (‘IND’) application with the U.S. Food and Drugs Administration for this alcohol-poisoning-related indication.”

To view the full press release, visit

About Safety Shot

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. The company plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published:

Los Angeles, CA
310.299.1717 Office

InvestorWire is powered by IBN